Personalized exercise shows promise for fatigue in rare blood cancers
NCT ID NCT07518940
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests whether a 12-week personalized exercise program can reduce fatigue and improve physical function in people with myeloproliferative neoplasms (MPN) and chronic myeloid leukemia (CML). Participants will do supervised aerobic and resistance training twice a week plus home exercise. The goal is to see if the program is safe, feasible, and helps with symptoms like fatigue and quality of life.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- supervised aerobic and resistance exercise program
- What this could lead to
- If successful, this could provide a safe, drug-free way to manage fatigue and improve quality of life for people with these rare blood cancers.
- What could go wrong
- This is a small, early feasibility study with only 25 participants, so results may not apply to everyone. Exercise may cause injury or other side effects, and benefits may not last after the program ends.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC MYELOID LEUKEMIA (CML) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
AO Ordine Mauriziano di Torino
Torino, To, Italy
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a hormone mimic curb the need for bloodletting in a blood cancer?
- Can a Dual-Action pill tame bone marrow tumors?
- Can a new daily pill shrink the spleen and ease myelofibrosis symptoms?
- Can a new drug reduce bloodletting for polycythemia vera?
- New blood marker duo could spot leukemia earlier
- A simple Note-Taking change could transform blood cancer care